The FDA has granted a supplemental biologics license application to expand the indication for ACAM2000 to include Monkeypox disease prevention in high-risk people, according to a news release from developer Emergent BioSolutions. Previously, the only indication was to prevent smallpox. What is ACAM2000? Existing human safety data and animal research show the vaccine’s effectiveness against … Continue reading FDA Approves Expanded Use of ACAM2000 for Monkeypox Prevention